REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 18th, 2005 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This REGISTRATION RIGHTS AGREEMENT, dated as of August 15, 2005 (this “Agreement”), is made by and among Sonus Pharmaceuticals, Inc., a Delaware corporation, with headquarters located at 22026 20th Avenue S.E., Bothell, Washington 98021 (the “Company”), and the investors named on the signature pages hereto (the “Initial Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 18th, 2005 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
____ An investment company registered under the Investment Company Act, acting for its own account or for the accounts of other qualified institutional buyers, that is part of a family of investment companies which own in the aggregate at least $100 million in securities of issuers, other than issuers that are affiliated with the investment company or are part of such family of investment companies.
